Athersys (ATHX) Announces Cooperation Agreement With HEALIOS K.K.

Go back to Athersys (ATHX) Announces Cooperation Agreement With HEALIOS K.K.

Athersys Announces Cooperation Agreement With HEALIOS K.K.

February 16, 2021 7:50 AM EST

CLEVELAND--(BUSINESS WIRE)-- Athersys, Inc. (NASDAQ: ATHX), a regenerative medicine company developing MultiStem® cell therapy, today announced that it has entered into a cooperation agreement with HEALIOS K.K. (Healios), the Companys largest shareholder and one of its commercial partners, and Dr. Hardy TS Kagimoto, a member of the Companys Board and the Chairman and Chief Executive Officer of Healios. The cooperation agreement is intended to reaffirm the mutual commitment to collaborative development of MultiStem in Japan.

Pursuant to the agreement, the parties commit to work in good faith to finalize... More